Patel K - Search Results

1

CRISPR/Cas9 Genome Editing for Tissue-Specific In Vivo Targeting: Nanomaterials and Translational Perspective.

Sahel DK, Vora LK, Saraswat A, Sharma S, Monpara J, D'Souza AA, Mishra D, Tryphena KP, Kawakita S, Khan S, Azhar M, Khatri DK, Patel K, Singh Thakur RR. Sahel DK, et al. Among authors: patel k. Adv Sci (Weinh). 2023 Jul;10(19):e2207512. doi: 10.1002/advs.202207512. Epub 2023 May 11. Adv Sci (Weinh). 2023. PMID: 37166046 Free PMC article. Review.

2

Development and characterization of an organic solvent free, proliposomal formulation of Busulfan using quality by design approach.

Chobisa D, Patel K, Monpara J, Patel M, Vavia P. Chobisa D, et al. Among authors: patel m, patel k. Int J Pharm. 2018 Jan 15;535(1-2):360-370. doi: 10.1016/j.ijpharm.2017.11.007. Epub 2017 Nov 7. Int J Pharm. 2018. PMID: 29126906

3

Nanoformulation of PROteolysis TArgeting Chimera targeting 'undruggable' c-Myc for the treatment of pancreatic cancer.

Saraswat A, Patki M, Fu Y, Barot S, Dukhande VV, Patel K. Saraswat A, et al. Among authors: patel k. Nanomedicine (Lond). 2020 Aug;15(18):1761-1777. doi: 10.2217/nnm-2020-0156. Epub 2020 Jul 23. Nanomedicine (Lond). 2020. PMID: 32698663

4

A novel gene therapy for neurodegenerative Lafora disease via EPM2A-loaded DLinDMA lipoplexes.

Vemana HP, Saraswat A, Bhutkar S, Patel K, Dukhande VV. Vemana HP, et al. Among authors: patel k. Nanomedicine (Lond). 2021 Jun;16(13):1081-1095. doi: 10.2217/nnm-2020-0477. Epub 2021 May 7. Nanomedicine (Lond). 2021. PMID: 33960213 Free PMC article.

5

Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro.

Vartak R, Patil SM, Saraswat A, Patki M, Kunda NK, Patel K. Vartak R, et al. Among authors: patel k. Nanomedicine (Lond). 2021 Jun;16(14):1187-1202. doi: 10.2217/nnm-2020-0475. Epub 2021 May 13. Nanomedicine (Lond). 2021. PMID: 33982600 Free PMC article.

6

In vitro assessment of a synergistic combination of gemcitabine and zebularine in pancreatic cancer cells.

Patki M, Saraswat A, Bhutkar S, Dukhande V, Patel K. Patki M, et al. Among authors: patel k. Exp Cell Res. 2021 Aug 15;405(2):112660. doi: 10.1016/j.yexcr.2021.112660. Epub 2021 May 25. Exp Cell Res. 2021. PMID: 34048785

7

Development of Dual ARV-825 and Nintedanib-Loaded PEGylated Nano-Liposomes for Synergistic Efficacy in Vemurafnib-Resistant Melanoma.

Fu Y, Saraswat A, Wei Z, Agrawal MY, Dukhande VV, Reznik SE, Patel K. Fu Y, et al. Among authors: patel k. Pharmaceutics. 2021 Jul 1;13(7):1005. doi: 10.3390/pharmaceutics13071005. Pharmaceutics. 2021. PMID: 34371697 Free PMC article.

8

Stromal disruption facilitating invasion of a 'nano-arsenal' into the solid tumor.

Fu Y, Saraswat AL, Monpara J, Patel K. Fu Y, et al. Among authors: patel k. Drug Discov Today. 2022 Apr;27(4):1132-1141. doi: 10.1016/j.drudis.2021.11.015. Epub 2021 Nov 22. Drug Discov Today. 2022. PMID: 34823002 Review.

9

Cannabidiol Inhibits In Vitro Human Liver Microsomal Metabolism of Remdesivir.

Saraswat A, Vartak R, Patki M, Patel K. Saraswat A, et al. Among authors: patel k. Cannabis Cannabinoid Res. 2023 Dec;8(6):1008-1018. doi: 10.1089/can.2021.0109. Epub 2021 Dec 16. Cannabis Cannabinoid Res. 2023. PMID: 34918945

10

Galactose-decorated liver tumor-specific nanoliposomes incorporating selective BRD4-targeted PROTAC for hepatocellular carcinoma therapy.

Saraswat A, Vemana HP, Dukhande VV, Patel K. Saraswat A, et al. Among authors: patel k. Heliyon. 2022 Jan 3;8(1):e08702. doi: 10.1016/j.heliyon.2021.e08702. eCollection 2022 Jan. Heliyon. 2022. PMID: 35036599 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,777 results

Search Page

Filters